Table 1:
Patient Demographics and Characteristics
| N (%) (N = 32) | |
|---|---|
| Age Median (range) | 67.3 (53–80.7) |
| Male Gender | 21 (66%) |
| Performance status | |
| 0 | 13 (41%) |
| 1 | 18 (56%) |
| 2 | 1 (3%) |
| Race/Ethnicity | |
| White | 28 (88%) |
| Black | 3 (9%) |
| Asian | 1 (3%) |
| Hispanic | 0 (0%) |
| Number of Prior Lines of Therapy for Stage IV Disease | |
| 0 | 8 (25%)* |
| 1 | 23 (72%) |
| 2 or more | 1 (3%) |
| Smoking Status | |
| Current Smoker | 13 (41%) |
| Former Smoker | 18 (56%) |
| Never Smoker | 1 (3%) |
| Brain Metastases | |
| Present | 2(6%) |
| Absent | 30 (94%) |
*
per protocol, patients were eligible if they received chemotherapy in the adjuvant or as part of combined modality therapy within one year of enrollment.